Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Isabelle Ray-Coquard, Axel Le Cesne, et al.. Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.
BMC Cancer, BioMed Central, 2018, 18 (1), pp.963.
⟨10.1186/s12885-018-4828-1⟩.
⟨inserm-02050851⟩